Ares Management plans to bring pharma consulting firm The Lockwood Group to market later this year, Axios Pro has learned. Ares has yet to hire a sell-side advisor for the company, which will be marketed on about $70 million of EBITDA, two sources say.
Read the full article: Ares Prepping The Lockwood Group for Sale //
Source: https://www.axios.com/pro/health-tech-deals/2026/03/24/ares-lockwood-group-sale